AVITA Medical, Inc. (RCEL) Profit Margin
AVITA Medical, Inc. (RCEL) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2019-06-30 | -458.57% |
| 2020-06-30 | -294.68% |
| 2021-06-30 | -90.94% |
| 2022-12-31 | -77.47% |
| 2023-12-31 | -70.56% |
| 2024-12-31 | -96.26% |
| 2025-12-31 | -67.85% |
How RCEL compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| IONS | Ionis Pharmaceuticals Inc. | -40.41% |
| MYGN | Myriad Genetics Inc. | -44.38% |
| OSUR | OraSure Technologies Inc. | -59.76% |
| HBIO | Harvard Bioscience Inc. | -65.51% |
| QTRX | Quanterix Corporation | -77.14% |
These are five companies in the same sector as RCEL with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get AVITA Medical, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("RCEL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RCEL | $7.60 | -2.19% | 0.96M |
| 3 | ||||
| 4 | ||||
| 5 |